Moderna
Happiness rating is 68 out of 100
3.7 out of 5 stars.
Write a review

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds – 
Ribbon cutting at 320 Bent St.Moderna Therapeutics
See all 2 Moderna photos

Focused on Corporate Social Responsibility

Moderna's CSR efforts are focused on the development of mRNA medicines - including potential medicines for public health needs - as well as on our employees, the environment, our communities and strong corporate governance.

What is mRNA Science?

Messenger RNA, or mRNA, plays a fundamental role in human biology, transferring the instructions stored in DNA to make the proteins required in every living cell. Our approach is to use mRNA medicines to instruct a patient’s own cells to produce proteins that could prevent, treat, or cure disease.

Delivering on the promise of mRNA therapies for rare diseases

Dr. Stephen Hoge, President, and Paolo Martini, Ph.D., CSO Rare Diseases, discuss newly published preclinical data supporting Moderna’s first rare liver disease development program, an mRNA therapeutic for methylmalonic acidemia (MMA).

Moderna’s Research Engine